129 related articles for article (PubMed ID: 17963371)
1. Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids.
Katona BW; Cummins CL; Ferguson AD; Li T; Schmidt DR; Mangelsdorf DJ; Covey DF
J Med Chem; 2007 Nov; 50(24):6048-58. PubMed ID: 17963371
[TBL] [Abstract][Full Text] [Related]
2. Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5.
Pellicciari R; Sato H; Gioiello A; Costantino G; Macchiarulo A; Sadeghpour BM; Giorgi G; Schoonjans K; Auwerx J
J Med Chem; 2007 Sep; 50(18):4265-8. PubMed ID: 17685603
[TBL] [Abstract][Full Text] [Related]
3. Back door modulation of the farnesoid X receptor: design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives.
Pellicciari R; Gioiello A; Costantino G; Sadeghpour BM; Rizzo G; Meyer U; Parks DJ; Entrena-Guadix A; Fiorucci S
J Med Chem; 2006 Jul; 49(14):4208-15. PubMed ID: 16821780
[TBL] [Abstract][Full Text] [Related]
4. Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid.
Pellicciari R; Costantino G; Camaioni E; Sadeghpour BM; Entrena A; Willson TM; Fiorucci S; Clerici C; Gioiello A
J Med Chem; 2004 Aug; 47(18):4559-69. PubMed ID: 15317466
[TBL] [Abstract][Full Text] [Related]
5. Bile acids and signal transduction: role in glucose homeostasis.
Nguyen A; Bouscarel B
Cell Signal; 2008 Dec; 20(12):2180-97. PubMed ID: 18634871
[TBL] [Abstract][Full Text] [Related]
6. 5Alpha-bile alcohols function as farnesoid X receptor antagonists.
Nishimaki-Mogami T; Kawahara Y; Tamehiro N; Yoshida T; Inoue K; Ohno Y; Nagao T; Une M
Biochem Biophys Res Commun; 2006 Jan; 339(1):386-91. PubMed ID: 16300737
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
Martínez-Fernández P; Hierro L; Jara P; Alvarez L
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
[TBL] [Abstract][Full Text] [Related]
8. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
Tiwari A; Maiti P
Drug Discov Today; 2009 May; 14(9-10):523-30. PubMed ID: 19429513
[TBL] [Abstract][Full Text] [Related]
9. Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo.
Matsubara T; Yoshinari K; Aoyama K; Sugawara M; Sekiya Y; Nagata K; Yamazoe Y
Drug Metab Dispos; 2008 Oct; 36(10):2058-63. PubMed ID: 18645036
[TBL] [Abstract][Full Text] [Related]
10. Enantiomeric deoxycholic acid: total synthesis, characterization, and preliminary toxicity toward colon cancer cell lines.
Katona BW; Rath NP; Anant S; Stenson WF; Covey DF
J Org Chem; 2007 Nov; 72(24):9298-307. PubMed ID: 17958446
[TBL] [Abstract][Full Text] [Related]
11. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
Sato H; Macchiarulo A; Thomas C; Gioiello A; Une M; Hofmann AF; Saladin R; Schoonjans K; Pellicciari R; Auwerx J
J Med Chem; 2008 Mar; 51(6):1831-41. PubMed ID: 18307294
[TBL] [Abstract][Full Text] [Related]
12. Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element.
Lu Y; Heydel JM; Li X; Bratton S; Lindblom T; Radominska-Pandya A
Drug Metab Dispos; 2005 Jul; 33(7):937-46. PubMed ID: 15821044
[TBL] [Abstract][Full Text] [Related]
13. Role of bile acids and bile acid receptors in metabolic regulation.
Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1.
Chatterjee B; Echchgadda I; Song CS
Methods Enzymol; 2005; 400():165-91. PubMed ID: 16399349
[TBL] [Abstract][Full Text] [Related]
15. Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines.
Katona BW; Anant S; Covey DF; Stenson WF
J Biol Chem; 2009 Jan; 284(5):3354-3364. PubMed ID: 19054763
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.
Adachi R; Honma Y; Masuno H; Kawana K; Shimomura I; Yamada S; Makishima M
J Lipid Res; 2005 Jan; 46(1):46-57. PubMed ID: 15489543
[TBL] [Abstract][Full Text] [Related]
17. Facile synthesis, aggregation behavior, and cholesterol solubilization ability of avicholic acid.
Mukhopadhyay S; Maitra U
Org Lett; 2004 Jan; 6(1):31-4. PubMed ID: 14703343
[TBL] [Abstract][Full Text] [Related]
18. Chemical Synthesis of Uncommon Natural Bile Acids: The 9α-Hydroxy Derivatives of Chenodeoxycholic and Lithocholic Acids.
Iida T; Namegawa K; Nakane N; Iida K; Hofmann AF; Omura K
Chem Pharm Bull (Tokyo); 2016 Sep; 64(9):1397-402. PubMed ID: 27319285
[TBL] [Abstract][Full Text] [Related]
19. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
[TBL] [Abstract][Full Text] [Related]
20. Pyrazolidine-3,5-dione derivatives as potent non-steroidal agonists of farnesoid X receptor: virtual screening, synthesis, and biological evaluation.
Deng G; Li W; Shen J; Jiang H; Chen K; Liu H
Bioorg Med Chem Lett; 2008 Oct; 18(20):5497-502. PubMed ID: 18815030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
